<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599813491706</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599813491706</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>American Academy of Audiology Response to Gurgel et al</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Carlson</surname><given-names>Deborah L.</given-names></name>
<degrees>PhD</degrees>
</contrib>
</contrib-group>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>149</volume>
<issue>2</issue>
<fpage>349</fpage>
<lpage>350</lpage>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>On behalf of the American Academy of Audiology (AAA), I would like to express concerns regarding “A New Standardized Format for Reporting Hearing Outcomes in Clinical Trials,” published in <italic>Otolaryngology–Head and Neck Surgery</italic> by Gurgel et al.<sup><xref ref-type="bibr" rid="bibr1-0194599813491706">1</xref></sup> While we support the concept of standardized reporting methods, a standard requires investigation for validity and reliability prior to blanket implementation. Examples in this article are hypothetical, thus untested, and lack guidance on the efficacy of statistical analyses of the proposed data sets.</p>
<p>The suggested “minimal reporting standards” are not appropriate for all auditory clinical trials populations. Therefore the statement in Table 1 that this standard “represents the first comprehensive minimal reporting standard for clinical trials <italic>in all forms of hearing loss</italic>” should be reconsidered. Requiring these as “minimal reporting standards” for any clinical trial published in the journals of <italic>OHNS</italic> and <italic>ON</italic> may preclude their publication of some excellent clinical trials.</p>
<p>The pure tone average recommended (.5, 1, 2, and 3 kHz) is not optimal for trials involving noise-induced (NIHL) or ototoxic-induced hearing loss and could be insensitive to their changes in threshold sensitivity. As a primary variable, this average would miss most NIHL changes, which occur from 2 to 4 kHz, and the averaging process will dilute changes at 3 kHz.<sup><xref ref-type="bibr" rid="bibr2-0194599813491706">2</xref></sup> Thus, even successful trials of new NIHL otoprotective pharmacologic agents or devices would show negative findings using these proposed standards.</p>
<p>These standards would be even less sensitive to ototoxic change to determine drug-induced ototoxicity or efficacy of a new otoprotective agent to prevent drug-induced hearing loss because most clinical ototoxins cause initial hearing loss above 10 kHz. Further, the proposed standard does not reference existing guidelines, ototoxic grading systems, or scales<sup><xref ref-type="bibr" rid="bibr3-0194599813491706">3</xref><xref ref-type="bibr" rid="bibr4-0194599813491706"/><xref ref-type="bibr" rid="bibr5-0194599813491706"/><xref ref-type="bibr" rid="bibr6-0194599813491706"/>-<xref ref-type="bibr" rid="bibr7-0194599813491706">7</xref></sup> (eg, AAA Position Statement on Ototoxicity Monitoring).<sup><xref ref-type="bibr" rid="bibr3-0194599813491706">3</xref></sup> To detect early change or measure the effectiveness of pharmaceutical otoprotectants will require auditory threshold information above 8 kHz as its primary outcome measure.</p>
<p>Use of word recognition is problematic in many clinical trials that may include non-English speakers, pediatric populations, ill patients, and in situations when time constraints are necessarily imposed. Word recognition also is not optimally analyzed in 10% increments but rather according to binomial distribution.<sup><xref ref-type="bibr" rid="bibr8-0194599813491706">8</xref></sup></p>
<p>While we appreciate the effort toward a standardized format for reporting data, this article does not present a useful standard for other stakeholders (eg, funding agencies, regulatory agencies) to evaluate study results across all forms of hearing data. Based on the information presented, we respectfully request that the current version of the Gurgel et al<sup><xref ref-type="bibr" rid="bibr1-0194599813491706">1</xref></sup> paradigm be withdrawn as a minimal reporting standard. We also would like to request the opportunity to work with the AAO-HNS to develop guidelines that better address the needs of cross-study comparisons and ensure best practices for those who use such guidelines.</p>
<p>Thank you for your consideration of this request. We look forward to further discussions in this area.</p>
<sec id="section1-0194599813491706">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> None.</p>
</sec>
<sig-block>
<sig>Deborah L. Carlson, PhD<break/>
<italic>President</italic><break/>
<italic>American Academy of Audiology Email: <email>dlcarlso@utmb.edu</email></italic></sig>
</sig-block>
</body>
<back>
<fn-group>
<fn fn-type="presented-at">
<p>No sponsorships or competing interests have been disclosed for this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599813491706">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gurgel</surname><given-names>RK</given-names></name>
<name><surname>Jackler</surname><given-names>RK</given-names></name>
<name><surname>Dobie</surname><given-names>RA</given-names></name>
<name><surname>Popelka</surname><given-names>GR</given-names></name>
</person-group>. <article-title>A new standardized format for reporting hearing outcome in clinical trials</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2012</year>;<volume>147</volume>(<issue>5</issue>):<fpage>803</fpage>-<lpage>807</lpage>.</citation>
</ref>
<ref id="bibr2-0194599813491706">
<label>2.</label>
<citation citation-type="book">
<collab>Department of Defense Instruction</collab>. <source>DOD Hearing Conservation Program (HCP)</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>DoDI</publisher-name>; <year>2004</year>.</citation>
</ref>
<ref id="bibr3-0194599813491706">
<label>3.</label>
<citation citation-type="web">
<collab>American Academy of Audiology Position Statement and Clinical Practice Guidelines: Ototoxicity Monitoring</collab>. <ext-link ext-link-type="uri" xlink:href="http://www.audiology.org/resources/documentlibrary/Documents/OtoMonGuidelines.pdf">http://www.audiology.org/resources/documentlibrary/Documents/OtoMonGuidelines.pdf</ext-link>. Published October 2009. <access-date>Accessed May 17, 2013</access-date>.</citation>
</ref>
<ref id="bibr4-0194599813491706">
<label>4.</label>
<citation citation-type="web">
<collab>American Speech-Language-Hearing Association: Audiologic management of individuals receiving cochleotoxic drug therapy guidelines</collab>. <ext-link ext-link-type="uri" xlink:href="http://www.asha.org/docs/html/GL1994-00003.html">http://www.asha.org/docs/html/GL1994-00003.html</ext-link>. Published 1994. <access-date>Accessed May 17, 2013</access-date>.</citation>
</ref>
<ref id="bibr5-0194599813491706">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brock</surname><given-names>P</given-names></name>
</person-group>. <article-title>Cisplatin ototoxicity in children: a practical grading system</article-title>. <source>Med Pediatr Oncol</source>. <year>1991</year>;<volume>19</volume>(<issue>4</issue>):<fpage>295</fpage>-<lpage>300</lpage>.</citation>
</ref>
<ref id="bibr6-0194599813491706">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brock</surname><given-names>PR</given-names></name>
<name><surname>Knight</surname><given-names>KR</given-names></name>
<name><surname>Freyer</surname><given-names>DR</given-names></name><etal/>
</person-group>. <article-title>Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston Ototoxicity Scale</article-title>. <source>J Clin Oncol</source>. <year>2012</year>;<volume>30</volume>:<fpage>2408</fpage>-<lpage>2417</lpage>.</citation>
</ref>
<ref id="bibr7-0194599813491706">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chang</surname><given-names>KW</given-names></name>
</person-group>. <article-title>Clinically accurate assessment and grading of ototoxicity</article-title>. <source>Laryngoscope</source>. <year>2011</year>;<volume>121</volume>(<issue>12</issue>):<fpage>2649</fpage>-<lpage>2657</lpage>.</citation>
</ref>
<ref id="bibr8-0194599813491706">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thornton</surname><given-names>AR</given-names></name>
<name><surname>Raffin</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Speech-discrimination scores modeled as a binomial variable</article-title>. <source>J Speech Hear Re</source>. <year>1978</year>;<volume>21</volume>(<issue>3</issue>):<fpage>507</fpage>-<lpage>518</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>